U.S. Markets closed

Novogen Limited (NVGN)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.89-0.01 (-1.11%)
At close: 3:53PM EDT
People also watch
NYMXPRANPBMDGENEMEIP

Novogen Limited

20 George Street
Level 5
Hornsby, NSW 2077
Australia
61 2 9472 4100
http://www.novogen.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Dr. James Garner M.A., MBA, MBBS, B.Sc (Hons), SAFin.Chief Exec. Officer, MD & Exec. Director145.85kN/A44
Ms. Gabrielle Heaton BBUS (ACC), CPADirector of Fin. and Admin.N/AN/AN/A
Kym RobinsDirector of Marketing & CommunicationsN/AN/AN/A
Dr. Peng Leong MBA, Ph.D.Chief Bus. OfficerN/AN/AN/A
Dr. Gordon Hirsch MBA, MBBCh, FCP(SA), BSc HonsChief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Novogen Limited engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). Its SBP technology platform offers Cantrixil, an intra-cavity anti-cancer agent for the treatment of ovarian cancer, malignant ascites, and malignant pleural effusion; and Trilexium for the treatment of brain cancers, neuroblastoma, and melanoma. Its ATM technology platform provides Anisina that destructs cancer cells cytoskeleton. The company is also developing various programs in the areas of regenerative medicine, facioscapulohumeral muscular dystrophy, and lysosomal storage disorder. Novogen Limited was founded in 1994 and is based in Hornsby, Australia.

Corporate Governance

Novogen Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.